Related Experiment Video

Updated: Jun 25, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

Hypercholesterolemia association with aortic stenosis of various etiologies

Murat Bülent Rabuş1, Nihan Kayalar, Başar Sareyyüpoğlu

  • 1Department of Cardiovascular Surgery, Koşuyolu Heart and Research Hospital, Istanbul, Turkey.

Journal of Cardiac Surgery
|March 10, 2009
PubMed

Insights

High cholesterol (hypercholesterolemia) is linked to aortic valve calcification, particularly in degenerative and congenital cases. Managing high cholesterol may help prevent or slow this aortic valve disease progression.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathology

Background:

  • Hypercholesterolemia is associated with aortic valve stenosis, sharing inflammatory similarities with atherosclerosis.
  • Investigating the specific role of hypercholesterolemia in aortic valve calcification across different etiologies is crucial.

Purpose of the Study:

  • To examine the influence of hypercholesterolemia on the development of aortic valve calcification.
  • To analyze this relationship in patients with rheumatic, congenital, and degenerative aortic stenosis.

Main Methods:

  • Analysis of 988 patients who underwent aortic valve replacement between 1985 and 2005.
  • Evaluation of hypercholesterolemia and high low-density lipoprotein (LDL) levels' impact on calcific aortic stenosis and massive aortic valve calcification within distinct etiological groups.

Main Results:

  • High serum cholesterol (>200 mg/dL) correlated with massive aortic valve calcification in all patients (p=0.003).
  • Hypercholesterolemia was linked to calcific aortic stenosis and massive calcification in degenerative (p=0.02, p=0.01) and congenital bicuspid aorta (p=0.02) etiologies.
  • High LDL and C-reactive protein levels were additional risk factors in the degenerative group.

Conclusions:

  • Hypercholesterolemia increases the risk of aortic valve calcification in degenerative and congenital conditions.
  • Preventive strategies targeting hypercholesterolemia may be vital in mitigating aortic valve calcification development.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...